Market Access & Commercialization Partner for Global Pharma Entering Azerbaijan

NEXA Pharm at a Glance

20+ years of leadership experience across multinational pharmaceutical organizations

End-to-end market entry: registration → pricing → market access → commercial launch

Full healthcare coverage: retail, hospital and public procurement channels

Focus markets: Azerbaijan, with regional CIS expansion capability

NEXA Pharm is a market-entry and commercialization partner supporting global pharmaceutical and biotech manufacturers in entering and expanding within the Azerbaijani market. We provide integrated expertise across regulatory affairs, pricing, market access and commercial execution.

With extensive experience in regulatory strategy, pricing systems, government affairs, hospital access and commercial operations in multinational environments, NEXA Pharm offers a deep understanding of Azerbaijan’s healthcare landscape and a strong foundation for successful and compliant market entry.

Our operational reach covers the retail pharmacy sector, hospital segment and the national public procurement market, ensuring comprehensive access across Azerbaijan’s healthcare system.

Core Areas of Expertise

Regulatory Affairs

Market Access

Pricing

Promotion and Commercial Execution

We work closely with international manufacturers to build transparent, long-term partnerships, supporting the introduction of high-quality and innovative therapies to patients in Azerbaijan.

At NEXA Pharm, our mission is to bridge global pharmaceutical innovation with local healthcare needs through efficient, compliant and sustainable market entry solutions.

Gulshaba Abbasova

CEO, NEXA Pharm
20+ years of senior leadership experience in global pharmaceutical companies

Gulshaba Abbasova brings more than two decades of senior leadership experience from leading multinational pharmaceutical organizations, including Janssen, MSD, Novo Nordisk and Astellas. Her background combines deep expertise in regulatory affairs, pricing, market access, commercial strategy and government engagement across complex and highly regulated markets.

Throughout her career, she has led successful product registrations, pricing approvals, reimbursement and market access initiatives, hospital access strategies and commercial launches across a broad range of therapeutic areas, including specialty care, biologics, biosimilars, rare diseases, endocrinology, rheumatology and oncology supportive care.

Her leadership style integrates strategic vision, operational excellence and long-term stakeholder relationships with healthcare authorities, clinicians and industry partners. This provides NEXA Pharm with a strong, credible and influential platform for supporting global pharmaceutical and biotech manufacturers entering and expanding within the Azerbaijani market.

Our mission is to accelerate access to high-quality and innovative medicines in Azerbaijan by providing global pharmaceutical companies with expert regulatory, pricing, market access and commercialization support.
We aim to bridge global innovation with local healthcare needs, ensuring that transformative therapies reach patients safely, efficiently and compliantly.

Integrity & Compliance

Patient-centricity

Transparency

Long-term partnerships

Scientific accuracy

Operational excellence

Deep expertise in Azerbaijan’s reimbursement and reference pricing framework

Proven track record in regulatory approvals, price setting and launch execution within highly regulated pharmaceutical markets

Established working interface with key stakeholders, including the Ministry of Health, State Agency of Mandatory Health Insurance (SAMHI), TABIB, hospitals and public procurement bodies

Multinational pharmaceutical mindset with strict compliance, governance and ethical standards

Our Advantage

Over 20 years of senior leadership experience in multinational pharmaceutical companies including Janssen-Cilag, MSD, Astellas and Novo Nordisk

Hands-on experience in obtaining price approvals and successful product registrations under Azerbaijan’s regulatory system

Strong and established relationships with key opinion leaders across rare diseases, endocrinology, nephrology, neurology and other specialty areas

Proven success in launching, positioning and sustainably growing brands in the Azerbaijani market

Full market entry and commercialization support covering registration → market access → promotion

At NEXA Pharm, we are committed to maintaining the highest standards of ethical conduct and regulatory compliance in all aspects of our operations. We recognize that integrity, transparency and responsibility are essential to building trust with our partners, healthcare institutions and regulatory authorities.

Our approach to compliance is guided by international pharmaceutical regulations, local legislation and globally recognized ethical frameworks. We ensure that all activities — from regulatory submissions and pricing processes to market access, promotion and tender participation — are carried out in full alignment with applicable laws and industry best practices.

Key principles of our compliance framework include:
• Integrity and transparency in all business interactions
• Strict adherence to national healthcare and pharmaceutical regulations
• Compliance with international standards of promotional and non-promotional activities
• Responsible engagement with healthcare professionals and institutions
• Protection of confidential and proprietary information
• Commitment to patient safety and ethical decision-making

We continuously strengthen our internal processes and promote a culture of accountability to ensure that our partners can rely on NEXA Pharm as a responsible and trustworthy representative in the Azerbaijani healthcare market.